AHCO AdaptHealth Corp
Price (delayed)
$10.82
Market cap
$1.46B
P/E Ratio
17.45
Dividend/share
N/A
EPS
$0.62
Enterprise value
$3.48B
AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and
Highlights
The net income has soared by 142% from the previous quarter and by 113% YoY
The EPS has surged by 138% since the previous quarter and by 112% year-on-year
Key stats
What are the main financial stats of AHCO
Market
Valuations
Earnings
Shares outstanding
134.87M
Market cap
$1.46B
Enterprise value
$3.48B
Price to earnings (P/E)
17.45
Price to book (P/B)
0.93
Price to sales (P/S)
0.44
EV/EBIT
13.47
EV/EBITDA
5.21
EV/Sales
1.07
Revenue
$3.26B
Gross profit
$681.09M
Operating income
$263.73M
Net income
$90.42M
EBIT
$258.33M
EBITDA
$667.61M
Free cash flow
$241.1M
Per share
Balance sheet
Liquidity
EPS
$0.62
EPS diluted
$0.61
Free cash flow per share
$1.8
Book value per share
$11.68
Revenue per share
$24.38
TBVPS
$12.76
Total assets
$4.49B
Total liabilities
$2.91B
Debt
$2.13B
Equity
$1.57B
Working capital
$188.8M
Debt to equity
1.36
Current ratio
1.33
Quick ratio
0.91
Net debt/EBITDA
3.03
Margins
Efficiency
Dividend
EBITDA margin
20.5%
Gross margin
20.9%
Net margin
2.8%
Operating margin
8.1%
Return on assets
2%
Return on equity
6%
Return on invested capital
7.9%
Return on capital employed
6.6%
Return on sales
7.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AHCO stock price
How has the AdaptHealth stock price performed over time
Intraday
-0.18%
1 week
5.15%
1 month
-4.92%
1 year
-3.39%
YTD
13.66%
QTD
-0.18%
Financial performance
How have AdaptHealth's revenue and profit performed over time
Revenue
$3.26B
Gross profit
$681.09M
Operating income
$263.73M
Net income
$90.42M
Gross margin
20.9%
Net margin
2.8%
AHCO's operating income has surged by 144% year-on-year
AdaptHealth's operating margin has surged by 143% YoY
The net margin has soared by 142% since the previous quarter and by 113% year-on-year
The net income has soared by 142% from the previous quarter and by 113% YoY
Growth
What is AdaptHealth's growth rate over time
Valuation
What is AdaptHealth stock price valuation
P/E
17.45
P/B
0.93
P/S
0.44
EV/EBIT
13.47
EV/EBITDA
5.21
EV/Sales
1.07
The EPS has surged by 138% since the previous quarter and by 112% year-on-year
AHCO's P/B is 90% lower than its 5-year quarterly average of 9.1 but 3.3% higher than its last 4 quarters average of 0.9
AHCO's equity is up by 8% year-on-year and by 3.6% since the previous quarter
The stock's price to sales (P/S) is 56% less than its 5-year quarterly average of 1.0 but 10% more than its last 4 quarters average of 0.4
Efficiency
How efficient is AdaptHealth business performance
The company's return on invested capital has surged by 144% YoY
The ROA has soared by 142% QoQ and by 114% YoY
The return on sales has surged by 142% year-on-year
The company's return on equity has surged by 141% QoQ and by 117% YoY
Dividends
What is AHCO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AHCO.
Financial health
How did AdaptHealth financials performed over time
The total assets is 54% more than the total liabilities
The current ratio has increased by 10% year-on-year and by 7% since the previous quarter
AHCO's quick ratio is up by 4.6% year-on-year
The debt is 36% greater than the equity
AHCO's debt to equity is down by 13% year-on-year and by 6% since the previous quarter
AHCO's equity is up by 8% year-on-year and by 3.6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.